Publication | Closed Access

Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study

Placebo-controlled Phase 2MedicineDuchenne Muscular DystrophyClinical TrialsPharmacotherapyDemand IiPharmacologyNeuromusculoskeletal Disorder